Passar para o conteúdo principal

Referências

  1. Bray et al. Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. Ca Cancer J Clin. 2018;68:394–424.
  2. O inquérito 2017 We Care foi editado e distribuído pela Atomik Research, Londres, Reino Unido entre 6 – 23 de janeiro de 2017. 
  3. National Cancer Institute. [Internet; citado a 5 de abril de 2019] Disponível a partir de: http://seer.cancer.gov/statfacts/html/urinb.html.
  4. Patient. [Internet; citado a 5 de abril de 2019] Disponível a partir de: http://patient.info/health/bladder-cancer-leaflet
  5. NHS. [Internet; citado a 5 de abril de 2019] Disponível a partir de: https://www.nhs.uk/conditions/bladder-cancer/symptoms/.
  6. Fight bladder cancer. [Internet; citado a 5 de abril de 2019] Disponível a partir de: http://fightbladdercancer.co.uk/learn/symptoms
  7. Gender and Bladder Cancer: A Collaborative Review of Etiology, Biology, and Outcomes. Dobruch J et al. Eur Urol. 2016;69:300-310.
  8. Richards K.A et al. Urinary tract infection-like symptom is associated with worse bladder cancer outcomes in the Medicare population: Implications for sex disparities. Int J Urol. 2016;23:42-47.
  9. Nicholson, B. D et al. Bladder cancer in women. BMJ. 2014;348:g2171–g2171.